|
|
(10 intermediate revisions by 5 users not shown) |
Line 4: |
Line 4: |
|
| |
|
| ==Overview== | | ==Overview== |
| | | All patients with listeriosis require [[antibiotic therapy]]. [[Ampicillin]], with or without [[gentamicin]], is the [[antibiotic]] of choice for the treatment of listeriosis. Patients intolerant to [[penicillin]]s may be managed with [[TMP/SMZ|trimethoprim-sulfamethoxazole]]. Duration of therapy depends on the clinical syndrome and may range from several days in non-complicated gastroenteritis to 6 weeks in [[endocarditis]] or [[encephalitis]]. Listerial [[gastroenteritis]] is frequently self-limited among healthy adults, but a short course of oral [[ampicillin]] may be considered among [[immunocompromised]] or [[pregnant]] individuals or those who have ingested food implicated in outbreaks. Non-gastroenteritis listeriosis often require hospitalization and [[Intravenous|intravenous (IV)]] [[antibiotic]] therapy. |
| [[Ampicillin]], with or without [[gentamicin]], is the preferred antibiotic for the treatment of listeriosis. Patients intolerant to [[penicillin]]s may be managed with [[TMP/SMZ|trimethoprim-sulfamethoxazole]]. The suggested minimum duration of therapy depends on the clinical syndrome. Listerial [[gastroenteritis]] is frequently self-limited but a short course of oral [[ampicillin]] may be considered in individuals with impaired [[cell-mediated immunity]] or those who have ingested food implicated in outbreaks. Listeria [[bacteremia]] requires at least 2 weeks of treatment, [[meningitis]] 3 weeks, [[endocarditis]] 4 to 6 weeks, and [[brain abscess]] or [[encephalitis|rhombencephalitis]] 6 weeks. | | ==Medical Therapy== |
| | | * '''Either [[Ampicillin]], [[amoxicillin]], or [[penicillin G]] is effective for the treatment of listeriosis.''' |
| ==Principles of Therapy== | | *Addition of an [[aminoglycoside]], which confers [[synergistic]] [[bactericidal]] effects to [[ampicillin]], is recommended for the treatment of listerial [[bacteremia]], [[endocarditis]], [[brain abscess]], [[meningitis]], or [[encephalitis|rhombencephalitis]].<ref>{{Cite journal | issn = 0098-7484 | volume = 261 | issue = 9 | pages = 1313–1320 | last = Gellin | first = B. G. | coauthors = C. V. Broome | title = Listeriosis | journal = JAMA: the journal of the American Medical Association | date = 1989-03-03 | pmid = 2492614 }}</ref> |
| | | *Alternatively, for patients unable to tolerate [[beta-lactam]]s, [[TMP/SMZ|trimethoprim-sulfamethoxazole]] may be administered. |
| * [[Ampicillin]], [[amoxicillin]], and [[penicillin G]] have been considered effective for listeriosis. Alternatively, For patients unable to tolerate [[beta-lactam]]s, [[TMP/SMZ|trimethoprim-sulfamethoxazole]] may be administered. [[Chloramphenicol]] is not regarded as an acceptable option due to high treatment failure and relapse rates.<ref>{{Cite journal | issn = 0162-0886 | volume = 4 | issue = 3 | pages = 665–682 | last = Stamm | first = A. M. | coauthors = W. E. Dismukes, B. P. Simmons, C. G. Cobbs, A. Elliott, P. Budrich, J. Harmon | title = Listeriosis in renal transplant recipients: report of an outbreak and review of 102 cases | journal = Reviews of Infectious Diseases | date = 1982-06 | pmid = 6750737 }}</ref> Addition of an [[aminoglycoside]], which confers [[synergistic]] [[bactericidal]] effects to [[ampicillin]], is recommended for the treatment of listerial [[bacteremia]], [[endocarditis]], [[brain abscess]], [[meningitis]], or [[encephalitis|rhombencephalitis]].<ref>{{Cite journal | issn = 0098-7484 | volume = 261 | issue = 9 | pages = 1313–1320 | last = Gellin | first = B. G. | coauthors = C. V. Broome | title = Listeriosis | journal = JAMA: the journal of the American Medical Association | date = 1989-03-03 | pmid = 2492614 }}</ref> | |
| | |
| * [[Meningitis]] is the most common clinical manifestation, and antibiotics that penetrate well into the [[cerebrospinal fluid]] should be chosen. [[Gastroenteritis]] caused by ''[[Listeria monocytogenes]]'' is usually self-limited and complete recovery typically occurs within 2 days. Persons who have ingested food implicated in outbreaks and who have a high risk of invasive illness may be treated with oral [[ampicillin]] or [[TMP/SMZ|trimethoprim-sulfamethoxazole]] for several days.<ref>{{Cite journal | issn = 1058-4838 | volume = 24 | issue = 1 | pages = 1–9; quiz 10-11 | last = Lorber | first = B. | title = Listeriosis | journal = Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America | date = 1997-01 | pmid = 8994747 }}</ref> | |
|
| |
|
| * The table below describes the recommended duration of therapy based upon the clinical syndrome:<ref>{{Cite journal | issn = 1058-4838 | volume = 24 | issue = 1 | pages = 1–9; quiz 10-11 | last = Lorber | first = B. | title = Listeriosis | journal = Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America | date = 1997-01 | pmid = 8994747 }}</ref><ref>{{Cite journal | issn = 0098-7484 | volume = 261 | issue = 9 | pages = 1313–1320 | last = Gellin | first = B. G. | coauthors = C. V. Broome | title = Listeriosis | journal = JAMA: the journal of the American Medical Association | date = 1989-03-03 | pmid = 2492614 }}</ref> | | * The table below describes the recommended duration of therapy based upon the clinical syndrome:<ref>{{Cite journal | issn = 1058-4838 | volume = 24 | issue = 1 | pages = 1–9; quiz 10-11 | last = Lorber | first = B. | title = Listeriosis | journal = Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America | date = 1997-01 | pmid = 8994747 }}</ref><ref>{{Cite journal | issn = 0098-7484 | volume = 261 | issue = 9 | pages = 1313–1320 | last = Gellin | first = B. G. | coauthors = C. V. Broome | title = Listeriosis | journal = JAMA: the journal of the American Medical Association | date = 1989-03-03 | pmid = 2492614 }}</ref> |
|
| |
|
| {| style="border: 0px; font-size: 90%; margin: 0 18px;" | | {| style="border: 0px; font-size: 90%; margin: 0 18px;" |
| | style="background: #4479BA; font-weight: bold; font-style: italic; color: #FFFFFF; padding: 5px 5px;" align=center | Clinical Syndrome | | | style="background: #4479BA; font-weight: bold; font-style: italic; color: #FFFFFF; padding: 5px 5px;" align=center | Listeriosis Clinical Syndrome |
| | style="background: #4479BA; font-weight: bold; font-style: italic; color: #FFFFFF; padding: 5px 5px;" align=center | Duration of Therapy | | | style="background: #4479BA; font-weight: bold; font-style: italic; color: #FFFFFF; padding: 5px 5px;" align=center | Duration of Antibiotic Therapy |
| |- | | |- |
| | style="background: #DCDCDC; padding: 5px 5px;" | Gastroenteritis, if indicated | | | style="background: #DCDCDC; padding: 5px 5px;" | Gastroenteritis, if indicated |
Line 44: |
Line 41: |
| |} | | |} |
|
| |
|
| ==Antibiotic Therapy for ''Listeria monocytogenes'' <SMALL><SMALL><SMALL><SMALL><SMALL>Adapted from ''Clin Infect Dis. 1997;24(1):1-9.'',<ref>{{Cite journal | issn = 1058-4838 | volume = 24 | issue = 1 | pages = 1–9; quiz 10-11 | last = Lorber | first = B. | title = Listeriosis | journal = Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America | date = 1997-01 | pmid = 8994747 }}</ref> ''Clin Infect Dis. 2005;40(9):1327-32.'',<ref>{{Cite journal | doi = 10.1086/429324 | issn = 1537-6591 | volume = 40 | issue = 9 | pages = 1327–1332 | last = Ooi | first = Say Tat | coauthors = Bennett Lorber | title = Gastroenteritis due to Listeria monocytogenes | journal = Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America | date = 2005-05-01 | pmid = 15825036 }}</ref> and ''Clin Infect Dis. 2004;39(9):1267-84.''<ref>{{Cite journal | doi = 10.1086/425368 | issn = 1537-6591 | volume = 39 | issue = 9 | pages = 1267–1284 | last = Tunkel | first = Allan R. | coauthors = Barry J. Hartman, Sheldon L. Kaplan, Bruce A. Kaufman, Karen L. Roos, W. Michael Scheld, Richard J. Whitley | title = Practice guidelines for the management of bacterial meningitis | journal = Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America | date = 2004-11-01 | pmid = 15494903 }}</ref></SMALL></SMALL></SMALL></SMALL></SMALL>== | | ===Antimicrobial Regimen=== |
| | | *1. '''Meningitis''' <ref>{{cite book | last = Bartlett | first = John | title = Johns Hopkins ABX guide : diagnosis and treatment of infectious diseases | publisher = Jones and Bartlett Learning | location = Burlington, MA | year = 2012 | isbn = 978-1449625580 }}</ref> |
| * <font color="#FF4C4C">'''Click on the following categories to expand treatment regimens.'''</font> | | :* Preferred regimen: [[Ampicillin]] 2g IV q4-6h {{withorwithout}} [[Gentamicin]] 1.7 mg/kg IV q8h for more than 3 weeks |
| <div style="-webkit-user-select: none;">
| | :* Alternative regimen: [[TMP-SMX]] 3-5 mg/kg (trimethoprim) IV q6h for more than 3 weeks |
| {|
| | *2. '''Bacteremia''' |
| | valign=top |
| | :* Preferred regimen: [[Ampicillin]] 2g IV q4-6h {{withorwithout}} [[Gentamicin]] 1.7 mg/kg IV q8h for 2 weeks |
| <div style="border-radius: 5px 5px 0 0; border: solid 1px #20538D; border-bottom: 0px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); height: 30px; line-height: 30px; width: 225px; background: #A1BCDD; text-align: center; margin: 0 18px;">
| | :* Alternative regimen: [[TMP-SMX]] 3-5 mg/kg (trimethoprim) q6h IV for 2 weeks |
| <font color="#FFF">
| | *3. '''Brain abscess or rhomboencephalitis''' |
| '''''L. monocytogenes''''' '''Infections'''
| | :* Preferred regimen: [[Ampicillin]] 2g IV q4-6h {{withorwithout}} [[Gentamicin]] 1.7 mg/kg IV q8h for 4-6 weeks |
| </font>
| | :* Alternative regimen: [[TMP-SMX]] 3-5 mg/kg (trimethoprim) q6h IV for 4-6 weeks |
| </div>
| | *4. '''Gastroenteritis''' |
| <div class="mw-customtoggle-table01" style="cursor: pointer; border-radius: 0 0 0 0; border: solid 1px #20538D; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); height: 30px; line-height: 30px; width: 225px; background: #4479BA; margin: 0 18px;">
| | :* Preferred regimen (1): [[Amoxicillin]] 2g IV q4-6h |
| <font color="#FFF">
| | :* Preferred regimen (2): [[TMP-SMX]] 3-5 mg/kg (trimethoprim) q6h IV for 7 days |
| ▸ '''Bacteremia'''
| |
| </font>
| |
| </div>
| |
| <div class="mw-customtoggle-table02" style="cursor: pointer; border-radius: 0 0 0 0; border: solid 1px #20538D; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); height: 30px; line-height: 30px; width: 225px; background: #4479BA; margin: 0 18px;">
| |
| <font color="#FFF">
| |
| ▸ '''Brain Abscess'''
| |
| </font>
| |
| </div>
| |
| <div class="mw-customtoggle-table03" style="cursor: pointer; border-radius: 0 0 0 0; border: solid 1px #20538D; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); height: 30px; line-height: 30px; width: 225px; background: #4479BA; margin: 0 18px;">
| |
| <font color="#FFF">
| |
| ▸ '''Endocarditis'''
| |
| </font>
| |
| </div>
| |
| <div class="mw-customtoggle-table04" style="cursor: pointer; border-radius: 0 0 0 0; border: solid 1px #20538D; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); height: 30px; line-height: 30px; width: 225px; background: #4479BA; margin: 0 18px;">
| |
| <font color="#FFF">
| |
| ▸ '''Gastroenteritis'''
| |
| </font>
| |
| </div>
| |
| <div class="mw-customtoggle-table05" style="cursor: pointer; border-radius: 0 0 0 0; border: solid 1px #20538D; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); height: 30px; line-height: 30px; width: 225px; background: #4479BA; margin: 0 18px;">
| |
| <font color="#FFF">
| |
| ▸ '''Meningitis'''
| |
| </font>
| |
| </div>
| |
| <div class="mw-customtoggle-table06" style="cursor: pointer; border-radius: 0 0 5px 5px; border: solid 1px #20538D; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); height: 30px; line-height: 30px; width: 225px; background: #4479BA; margin: 0 18px;">
| |
| <font color="#FFF">
| |
| ▸ '''Rhombencephalitis'''
| |
| </font>
| |
| </div>
| |
| | valign=top |
| |
| {| class="mw-collapsible mw-collapsed" id="mw-customcollapsible-table01" style="background: #FFFFFF;"
| |
| | valign=top |
| |
| {| style="float: left; cellpadding=0; cellspacing= 0; width: 400px;"
| |
| ! style="height: 30px; line-height: 30px; background: #4479BA; border: 0px; font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=center | {{fontcolor|#FFF|''Listeria monocytogenes'', Bacteremia<sup>¶</sup>}}
| |
| |-
| |
| | style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=center | '''''Preferred Regimen'''''
| |
| |-
| |
| | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ampicillin]] 2 g IV q4h'''''<BR> OR <BR> ▸ '''''[[Penicillin G]] 4 MU IV q4h'''''
| |
| |-
| |
| | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | PLUS
| |
| |-
| |
| | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Gentamicin]] 2 mg/kg IV load, then 1.7 mg/kg IV q8h'''''
| |
| |-
| |
| | style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=center | '''''Alternative Regimen'''''
| |
| |-
| |
| | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[TMP/SMZ]] 10—20 mg/kg/day IV q6—12h''''' (TMP component)<BR> OR <BR> ▸ '''''[[Meropenem]] 2 g IV q8h'''''
| |
| |-
| |
| | style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=left | <sup>¶</sup><SMALL> '''Minimum duration of therapy: 2 weeks''' </SMALL>
| |
| |-
| |
| |}
| |
| |}
| |
| {| class="mw-collapsible mw-collapsed" id="mw-customcollapsible-table02" style="background: #FFFFFF;"
| |
| | valign=top |
| |
| {| style="float: left; cellpadding=0; cellspacing= 0; width: 400px;"
| |
| ! style="height: 30px; line-height: 30px; background: #4479BA; border: 0px; font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=center | {{fontcolor|#FFF|''Listeria monocytogenes'', Brain Abscess<sup>†</sup>}}
| |
| |-
| |
| | style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=center | '''''Preferred Regimen'''''
| |
| |-
| |
| | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ampicillin]] 2 g IV q4h'''''<BR> OR <BR> ▸ '''''[[Penicillin G]] 4 MU IV q4h'''''
| |
| |-
| |
| | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | PLUS
| |
| |-
| |
| | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Gentamicin]] 2 mg/kg IV load, then 1.7 mg/kg IV q8h'''''
| |
| |-
| |
| | style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=center | '''''Alternative Regimen'''''
| |
| |-
| |
| | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[TMP/SMZ]] 10—20 mg/kg/day IV q6—12h''''' (TMP component)<BR> OR <BR> ▸ '''''[[Meropenem]] 2 g IV q8h'''''
| |
| |-
| |
| | style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=left | <sup>†</sup><SMALL> '''Minimum duration of therapy: 6 weeks''' </SMALL>
| |
| |-
| |
| |}
| |
| |}
| |
| {| class="mw-collapsible mw-collapsed" id="mw-customcollapsible-table03" style="background: #FFFFFF;" | |
| | valign=top |
| |
| {| style="float: left; cellpadding=0; cellspacing= 0; width: 400px;" | |
| ! style="height: 30px; line-height: 30px; background: #4479BA; border: 0px; font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=center | {{fontcolor|#FFF|''Listeria monocytogenes'', Endocarditis<sup>§</sup>}}
| |
| |-
| |
| | style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=center | '''''Preferred Regimen'''''
| |
| |-
| |
| | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ampicillin]] 2 g IV q4h'''''<BR> OR <BR> ▸ '''''[[Penicillin G]] 4 MU IV q4h'''''
| |
| |-
| |
| | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | PLUS
| |
| |-
| |
| | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Gentamicin]] 2 mg/kg IV load, then 1.7 mg/kg IV q8h'''''
| |
| |-
| |
| | style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=center | '''''Alternative Regimen'''''
| |
| |-
| |
| | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[TMP/SMZ]] 10—20 mg/kg/day IV q6—12h''''' (TMP component)<BR> OR <BR> ▸ '''''[[Meropenem]] 2 g IV q8h'''''
| |
| |-
| |
| | style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=left | <sup>§</sup><SMALL> '''Minimum duration of therapy: 4—6 weeks''' </SMALL>
| |
| |-
| |
| |}
| |
| |}
| |
| {| class="mw-collapsible mw-collapsed" id="mw-customcollapsible-table04" style="background: #FFFFFF;"
| |
| | valign=top |
| |
| {| style="float: left; cellpadding=0; cellspacing= 0; width: 400px;"
| |
| ! style="height: 30px; line-height: 30px; background: #4479BA; border: 0px; font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=center | {{fontcolor|#FFF|''Listeria monocytogenes'', Gastroenteritis}}
| |
| |-
| |
| | style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=center | '''''Preferred Regimen'''''
| |
| |-
| |
| | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ Antimicrobial therapy is <u>'''not'''</u> warranted in most cases.
| |
| |-
| |
| | style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=center | '''''Alternative Regimen''''' <BR> <SMALL> (For Outbreaks and Invasive Diseases) </SMALL>
| |
| |-
| |
| | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ampicillin]] 500 mg PO q6h x 5 days'''''<BR> OR <BR> ▸ '''''[[TMP/SMZ]] 160/800 mg PO q12h x 5 days'''''
| |
| |-
| |
| |}
| |
| |}
| |
| {| class="mw-collapsible mw-collapsed" id="mw-customcollapsible-table05" style="background: #FFFFFF;" | |
| | valign=top |
| |
| {| style="float: left; cellpadding=0; cellspacing= 0; width: 400px;" | |
| ! style="height: 30px; line-height: 30px; background: #4479BA; border: 0px; font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=center | {{fontcolor|#FFF|''Listeria monocytogenes'', Meningitis<sup>‡</sup>}}
| |
| |-
| |
| | style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=center | '''''Preferred Regimen'''''
| |
| |-
| |
| | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ampicillin]] 2 g IV q4h'''''<BR> OR <BR> ▸ '''''[[Penicillin G]] 4 MU IV q4h'''''
| |
| |-
| |
| | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | PLUS
| |
| |-
| |
| | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Gentamicin]] 2 mg/kg IV load, then 1.7 mg/kg IV q8h'''''
| |
| |-
| |
| | style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=center | '''''Alternative Regimen'''''
| |
| |-
| |
| | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[TMP/SMZ]] 10—20 mg/kg/day IV q6—12h''''' (TMP component)<BR> OR <BR> ▸ '''''[[Meropenem]] 2 g IV q8h'''''
| |
| |-
| |
| | style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=left | <sup>‡</sup><SMALL> '''Minimum duration of therapy: 3 weeks''' </SMALL>
| |
| |-
| |
| |}
| |
| |}
| |
| {| class="mw-collapsible mw-collapsed" id="mw-customcollapsible-table06" style="background: #FFFFFF;"
| |
| | valign=top |
| |
| {| style="float: left; cellpadding=0; cellspacing= 0; width: 400px;"
| |
| ! style="height: 30px; line-height: 30px; background: #4479BA; border: 0px; font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=center | {{fontcolor|#FFF|''Listeria monocytogenes'', Rhombencephalitis<sup>†</sup>}}
| |
| |-
| |
| | style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=center | '''''Preferred Regimen'''''
| |
| |-
| |
| | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ampicillin]] 2 g IV q4h'''''<BR> OR <BR> ▸ '''''[[Penicillin G]] 4 MU IV q4h'''''
| |
| |-
| |
| | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | PLUS
| |
| |-
| |
| | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Gentamicin]] 2 mg/kg IV load, then 1.7 mg/kg IV q8h'''''
| |
| |-
| |
| | style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=center | '''''Alternative Regimen'''''
| |
| |-
| |
| | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[TMP/SMZ]] 10—20 mg/kg/day IV q6—12h''''' (TMP component)<BR> OR <BR> ▸ '''''[[Meropenem]] 2 g IV q8h'''''
| |
| |-
| |
| | style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=left | <sup>†</sup><SMALL> '''Minimum duration of therapy: 6 weeks''' </SMALL>
| |
| |-
| |
| |}
| |
| |}
| |
| |}</div>
| |
|
| |
|
| ==References== | | ==References== |
Line 212: |
Line 59: |
| {{reflist|2}} | | {{reflist|2}} |
|
| |
|
| [[Category:Bacterial diseases]] | | {{WH}} |
| | {{WS}} |
| | |
| | [[Category:Emergency mdicine]] |
| [[Category:Disease]] | | [[Category:Disease]] |
| | [[Category:Up-To-Date]] |
| [[Category:Infectious disease]] | | [[Category:Infectious disease]] |
| | [[Category:Neurology]] |
| | [[Category:Gastroenterology]] |